Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Delivers inSelect Location
This article will discuss: What GLP-1s are
The framing throughout is published research observation these are research compounds studied in preclinical and clinical research, with one (tesamorelin/Egrifta) having pharmaceutical approval and the others operating in research peptide and (in CJC-1295's case) compounding pharmacy contexts
Retatrutide adds GIP receptor activation that survodutide lacks, making it a triple agonist (GIP + GLP-1 + glucagon) versus survodutides dual agonism (GLP-1 + glucagon)
And thank you, Louise Cunningham, for facilitating the interview
US$ 25.74
US$ 26.98
US$ 24.82
US$ 22.69
US$ 28.69
